Association between acneiform eruption grade and survival outcomes in metastatic colorectal cancer patients treated with epidermal growth factor receptor inhibitors
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://data.mendeley.com/datasets/nkfw9k2chm
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary figures for Ong et al. Association between acneiform eruption grade and survival outcomes in metastatic colorectal cancer patients treated with epidermal growth factor receptor inhibitors.
Supplementary figure 1: Progression-free survival in mCRC patients on EGFRis.
Supplementary figure 1 legend: EGFRis, epidermal growth factor receptor inhibitors; g0, grade 0 rash; g1, grade 1 rash; g2/g3, grade 2/grade 3 rash; mCRC, metastatic colorectal cancer
Median progression-free survival for grades 0, 1, and 2/3 rashes were 3.0, 5.5, and 5.1 months, respectively (p<0.001).
Supplementary figure 2. Overall survival in mCRC patients on EGFRis.
Supplementary figure 2 legend: EGFRis, epidermal growth factor receptor inhibitors; g0, grade 0 rash; g1, grade 1 rash; g2/g3, grade 2/grade 3 rash; mCRC, metastatic colorectal cancer
Median overall survival for grades 0, 1, and 2/3 rashes were 6.8, 18.0, and 18.1 months, respectively (p<0.001).
创建时间：
2025-03-18
